Thompson Davis & Co., Inc. Pfizer Inc Transaction History

Thompson Davis & Co., Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$46.53 - $55.17 $292,208 - $346,467	-6,280 Reduced 42.49%	8,500 $446,000
Q2 2022 Aug 02, 2022	BUY	$46.53 - $55.17 $292,208 - $346,467	6,280 Added 73.88%	14,780 $775,000
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $83,493 - $103,459	-1,825 Reduced 17.68%	8,500 $440,000
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $408,035 - $604,843	9,875 Added 2194.44%	10,325 $610,000
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $20,682 - $25,086	-600 Reduced 57.14%	450 $20,000
Q2 2018 Aug 03, 2018	BUY	$32.98 - $35.16 $3,957 - $4,219	120 Added 12.9%	1,050 $38,000
Q1 2018 May 02, 2018	SELL	$31.91 - $37.02 $13,083 - $15,178	-410 Reduced 30.6%	930 $33,000
Q4 2017 Feb 05, 2018	SELL	$33.26 - $35.29 $80,555 - $85,472	-2,422 Reduced 64.38%	1,340 $49,000
Q3 2017 Oct 30, 2017	SELL	$31.0 - $34.15 $118,978 - $131,067	-3,838 Reduced 50.5%	3,762 $134,000
Q2 2017 Aug 10, 2017	BUY	N/A	7,600	7,600 $255,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.